Dear Colleagues,

Facilitate Live is very pleased to welcome you to our upcoming 3rd DCT, Hybrid & Centralised Clinical Trials World Congress 2027 Europe brings together a global community united by a common purpose: to shape a future where clinical research is more accessible, more connected and more responsive to the needs of people everywhere. At a time when healthcare is evolving rapidly and expectations around participation, transparency and innovation continue to rise, this Congress offers a space for reflection, collaboration and forward‐looking ambition.

Across two days, leaders from every corner of the research ecosystem will gather not simply to discuss new approaches, but to imagine what is possible when diverse perspectives come together. Whether representing pharma, biotech, CROs, academic institutions, patient organisations or government agencies, each participant contributes a vital piece of the broader vision.  The Congress celebrates this diversity of expertise, recognising that meaningful progress in clinical research can only be achieved when all voices are heard and valued.

The programme will explore how modern trial models can be shaped to better serve science and society. It will encourage attendees to look beyond individual technologies or operational processes and instead consider the bigger picture: how we design studies that are more inclusive, how we build systems that are more resilient, and how we create experiences that respect and empower the people who participate. The conversations throughout the event will highlight the importance of flexibility, empathy and shared responsibility in advancing research that truly reflects the world it aims to improve.

A central theme of the Congress is the belief that innovation is not only about new tools, but about new ways of thinking. As digital capabilities expand and remote approaches become more common, the opportunity emerges to rethink long‐standing assumptions about how trials must operate. This gathering encourages attendees to embrace curiosity, challenge convention and explore how modern methods can coexist with trusted foundations. It is an invitation to imagine trial models that are both scientifically rigorous and deeply human‐centred.

Equally important is the recognition that trust and transparency are essential to the future of research. As trials evolve, so must the ways we communicate, engage and collaborate with participants and communities. The Congress emphasises the importance of listening, truly listening, to the experiences, concerns and aspirations of patients. Their voices guide the direction of innovation and remind us that every advancement ultimately serves individuals and families seeking hope, healing and progress.

Throughout the event, attendees are encouraged to connect, share and build relationships that extend beyond the Congress itself. The challenges facing clinical research are complex, but they are also shared. By working together, across sectors, disciplines and borders, we can create trial ecosystems that are more inclusive, more efficient and more capable of meeting the needs of a changing world.

The 3rd DCT, Hybrid & Centralised Trials World Congress 2027 Europe is more than a meeting.
It is a collective commitment to shaping a future where research is accessible, equitable and grounded in collaboration. It is a celebration of what we can achieve when we unite around a shared vision: advancing clinical trials that honour both scientific excellence and the people at the heart of every study.

We look forward to welcoming you to the DCT congress!

Sincerely yours,

Jocelyn Raguindin
Conference Director
Facilitate Live